Philadelphia Trust Company’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Philadelphia Trust Company’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,825	Closed	-$44.2K	–	192
2015 Q2	$44.2K	Buy	+1,825	New	+$65.4K	0.16%	90

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Philadelphia Trust Company's BRLI Position: Q3 2015 in Review

Philadelphia Trust Company sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 1,825 shares — an estimated $44.2K sold.

Philadelphia Trust Company first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $44.2K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Philadelphia Trust Company reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Philadelphia Trust Company sold 1,825 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $44.2K.
Philadelphia Trust Company first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
Philadelphia Trust Company's BIO-REFERENCE LABS INC-NEW- position peaked at $44.2K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Philadelphia Trust Company's 13F filing for Q3 2015, filed 16 Nov 2015.